April 22, 2025

In a volatile global market, the UK's FTSE 100 stands out, rising 0.3% amid positive economic signals and sector strength, highlighting its resilience...
Oil prices have surged, influenced by equity market rebounds and geopolitical tensions...
Panmure Liberum maintains a confident outlook on the company, highlighting its strong fundamentals and future opportunities...
Emerging markets are gaining traction as investors pivot away from US assets, driven by shifts in economic confidence and opportunities for growth in undervalued regions...
Adam Forsyth highlights how a timely £8.5 million loan from Cardiff Capital Region’s Strategic Premises Fund is helping the company firm up progress on its 240MWh AW1 battery energy storage system (BESS) project...
Longspur Research, authored by analyst Adam Forsyth, highlights that the company's strategic focus on flexibility remains a key strength, especially as new bids emerge in the battery storage space...
BlackRock Latin American Investment Trust plc (LON:BRLA) shares valuable insights in its latest portfolio update as of March 31, 2025. Discover performance highlights and asset details...
BlackRock Energy and Resources Income Trust plc (LON:BERI) shares its portfolio update as of March 31, 2025, highlighting market performance and investment strategies...
Discover the latest updates from BlackRock Income and Growth Investment Trust plc (LON:BRIG). Explore performance metrics and insights as of March 31, 2025...
Stay informed with the latest insights from VinaCapital Vietnam Opportunity Fund Limited's monthly report for March 2025, detailing key updates and shareholder information...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Zotefoams plc has released its 2024 Annual Report and details for the 2025 AGM set for May 22, 2025. Discover key insights and compliance updates here...
Search

Funds

Reports

In a volatile global market, the UK's FTSE 100 stands out, rising 0.3% amid positive economic signals and sector strength, highlighting its resilience...
Oil prices have surged, influenced by equity market rebounds and geopolitical tensions...
Panmure Liberum maintains a confident outlook on the company, highlighting its strong fundamentals and future opportunities...
Emerging markets are gaining traction as investors pivot away from US assets, driven by shifts in economic confidence and opportunities for growth in undervalued regions...
Adam Forsyth highlights how a timely £8.5 million loan from Cardiff Capital Region’s Strategic Premises Fund is helping the company firm up progress on its 240MWh AW1 battery energy storage system (BESS) project...
Longspur Research, authored by analyst Adam Forsyth, highlights that the company's strategic focus on flexibility remains a key strength, especially as new bids emerge in the battery storage space...
BlackRock Latin American Investment Trust plc (LON:BRLA) shares valuable insights in its latest portfolio update as of March 31, 2025. Discover performance highlights and asset details...
BlackRock Energy and Resources Income Trust plc (LON:BERI) shares its portfolio update as of March 31, 2025, highlighting market performance and investment strategies...
Discover the latest updates from BlackRock Income and Growth Investment Trust plc (LON:BRIG). Explore performance metrics and insights as of March 31, 2025...
Stay informed with the latest insights from VinaCapital Vietnam Opportunity Fund Limited's monthly report for March 2025, detailing key updates and shareholder information...
DCC plc has agreed to sell its healthcare division to HealthCo Investment for £1.05 billion, streamlining operations and enhancing shareholder value...
The DESTINY-Breast09 Phase III trial of Enhertu marks a breakthrough for HER2-positive metastatic breast cancer, showcasing superior efficacy over traditional therapies...
HUTCHMED has successfully completed patient enrollment for a Phase II trial of savolitinib, targeting gastric cancer patients with MET amplification...
Zotefoams plc has released its 2024 Annual Report and details for the 2025 AGM set for May 22, 2025. Discover key insights and compliance updates here...
Search

Funds

April 22, 2025

FTSE 100

Funds